Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.90
- Piotroski Score 7.00
- Grade Overweight
- Symbol (NUVA)
- Company NuVasive, Inc.
- Price $39.75
- Changes Percentage (-2.24%)
- Change -$0.91
- Day Low $39.51
- Day High $40.96
- Year High $49.53
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment. The company also offers cervical total disc replacement technology for cervical spinal fusion surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring services and support; and Pulse platform, a software ecosystem that integrates multiple hardware technologies into a single, condensed footprint in the operating room. In addition, it provides expandable growing rod implant systems for the treatment of early-onset scoliosis; various biologics that are used to aid in the spinal fusion or bone healing process; Precice, an intramedullary implant device that utilizes the MAGEC technology to non-invasively lengthen the femur and tibia; and onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/06/2023
- Fiscal Year End N/A
- Average Stock Price Target $60.00
- High Stock Price Target $64.00
- Low Stock Price Target $50.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.53
- Trailing P/E Ratio 75
- Forward P/E Ratio 75
- P/E Growth 75
- Net Income $40.41 M
Income Statement
Quarterly
Annual
Latest News of NUVA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
MSCI adds five Indian stocks to key index; Nuvama sees $2.5 billion inflows
MSCI added 5 Indian companies to its Global Standard Index, increasing India's weightage to 20%, closing the gap with China. This move will attract $2.5 billion in passive inflows, with expectations o...
By Yahoo! Finance | 2 weeks ago -
Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline
A list of top NYSE penny stocks includes Nuvation Bio Inc. Amid US Federal Reserve rate cuts, small-cap stocks are gaining attention for potential growth. Analysts see value in small-cap investments, ...
By Yahoo! Finance | 2 weeks ago -
Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35
The article discusses the potential of biotech stocks under $20, focusing on Nuvation Bio Inc. and its promising pipeline in oncology. Despite risks, the biotech industry shows rapid growth driven by ...
By Yahoo! Finance | 1 month ago
